Mitsubishi Fuel Chemical Firm (MGC), a chemical and life science expertise firm, is collaborating with Alerje, a Emergency medication and meals allergy administration firm working to remodel allergy analysis and remedy worldwide.
The alliance goals to create a complete, personalised allergy care technique to enhance affected person outcomes and high quality of life.
Key parts of the collaboration embrace the 2 firms working collectively to convey the newest allergy diagnostic platforms to the U.S. market and integrating meals allergy applied sciences designed to offer a holistic view of personalised allergy care.
This collaboration coincides with MGC’s long-term plans for the medical and meals industries.
“Partnering with MGC is a vital milestone in our mission to enhance the lives of hundreds of thousands of individuals,” Alerje founder and CEO Javier Evelyn stated in a press release.
“By combining our strengths, we’re poised to make unprecedented advances in allergy analysis and administration.”
The 2 firms declare their collaboration combines higher testing and modern remedies with the objective of fixing the way in which folks stay with meals allergic reactions.
“Collectively, our objective is to set a brand new normal in allergy care, leveraging our mixed applied sciences and experience to handle unmet wants within the U.S. and Japanese markets,” Yoshinori Isahaya, director and managing government officer of MGC, stated in a press release.
bigger pattern
Different companies concerned in meals allergic reactions embrace Harvard Medical College constructed a point-of-use meals allergen detector in 2017 that may be mounted on a keychain and check in minutes. The gadget is designed to detect main antigens with a sensitivity nicely beneath regulatory limits.
2016, 6SensorLabs, a smartphone-enabled allergen testing firm that modified its identify to Nima, raised $9.2 million, permitting the corporate to create a line of meals testing units. Nima used the funds to promote meals sensors for peanuts and dairy merchandise.
2023, Alerje obtained a Part II grant from the Nationwide Science Basis’s Small Enterprise Innovation Analysis Program. The $1 million grant will improve the capability of the corporate’s synthetic intelligence digital platform and assist increase manufacturing of its epinephrine auto-injector answer.
